Viewing Study NCT04202705


Ignite Creation Date: 2025-12-25 @ 3:14 AM
Ignite Modification Date: 2026-03-02 @ 4:12 AM
Study NCT ID: NCT04202705
Status: COMPLETED
Last Update Posted: 2023-01-30
First Post: 2019-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875
Sponsor: Byondis B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ADC View
None 5T4 View
None solid tumors View
None duocarmycin View